Response to 'Outcomes and costs associated with PHiD-CV, a new protein D conjugate pneumococcal vaccine, in four countries'.Comments Comment on: Vaccine. 2010 Nov 19;28 Suppl 6:G23-9; PMID: 21075266

摘要

A recent supplement article by Talbird, Taylor, Knoll, Frostad, and Garcia Marti reported estimates of public health impact and cost-effectiveness of the 10-valent pneumococcal conjugate vaccine compared with the 7-valent vaccine. Although the analysis applies a decision analytic model and modeling methodologies that are scientifically sound, many of the assumptions presented in the paper are inconsistent with the current evidence. Copyright Copyright 2011 Elsevier Ltd. All rights reserved.CAS Registry/EC Number/Name of Substance 0 (Pneumococcal Vaccines).